Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014
Urologix, Inc. reported earnings results for the third quarter and nine months ended March 31, 2014. The company has reported that net loss for the third quarter ended March 31, 2014 was $1.66 million, or $0.08 loss per share, compared to a net loss of $1 million, or $0.05 loss per share, for the same quarter ended March 31, 2013. Sales for the third quarter ended March 31, 2014 were $3.36 million, compared to $4.08 million for the same quarter ended March 31, 2013.
Net loss for the nine months ended March 31, 2014 was $4.08 million, or $0.19 loss per share, compared to a net loss of $3.04 million, or $0.15 loss per share, for the same period ended March 31, 2013. Sales for the nine months ended March 31, 2014 were $10.94 million, compared to $12.40 million for the same period ended March 31, 2013.